Intercytex

Infobox_Company
company_name = Intercytex
company_
company_type = Public (lse|ICX)
company_slogan =
foundation = 2000
location = flagicon|UK Cambridge, UK
key_people = Nick Higgins (CEO)
Richard Moulson (CFO)
Paul Kemp (CSO)
num_employees = 80 [ [http://www.intercytex.com/icx/about/profile Intercytex - Company profile] ]
industry = Biotechnology
products = 4 in clinical development
homepage = [http://www.intercytex.com www.intercytex.com]
revenue =
net_income =

Intercytex is a biopharmaceutical company based in Cambridge, UK.

It was founded in 2000 and is the leading developer of regenerative medicine products to restore skin and hair [ [http://www.tradingmarkets.com/.site/news/Stock%20News/1213166 TradingMarkets - "Intercytex Group plc: Positive clinical data continues to be generated across product portfolio"] ] .

Products

Currently the company doesn't have a marketed product, though its pipeline includes one drug in phase III clinical development, two in phase II clinical development, and one in phase I clinical development [ [http://www.intercytex.com/icx/products/pipeline Intercytex - Clinical pipeline] ] .

Latest Research Developments

In June 2008, Intercytex announced positive results of their Phase II trial for a form of cloning based Hair multiplication technique called follicular cell implantation [ [http://www.timesonline.co.uk/tol/life_and_style/men/article4045906.ece Feeling a bit thin on top? This cloning story may restore your crowning glory - Times Online] ] . The treatment is being hailed as a major advance in hair restoration and is backed by a £1.9 million government grant. The treatment is predicted to be availale to patients within 5 years.

References

External links

* [http://www.intercytex.com www.intercytex.com]